John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNTV
476
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $14.2M | 0.04% |
874,450
+156,211
| +22% | +$2.61M |
|
477
Rambus
RMBS
$9.9B
| $14.2M | 0.04% |
444,898
+261,009
| +142% | +$7.22M |
|
|
JHG
478
DELISTED
Janus Henderson
JHG
| $14.1M | 0.04% |
403,457
+378,645
| +1,526% | +$13.6M |
|
479
Wyndham Hotels & Resorts
WH
$5.54B
| $14.1M | 0.04% |
166,459
-133,216
| -44% | -$11.3M |
|
480
FIGS
FIGS
$2.44B
| $14.1M | 0.04% |
+653,576
| New | +$13M |
|
481
Mattel
MAT
$4.15B
| $14M | 0.04% |
+629,667
| New | +$14.4M |
|
482
Manhattan Associates
MANH
$12.5B
| $14M | 0.04% |
100,605
-11,539
| -10% | -$1.55M |
|
483
Colliers International
CIGI
$5.47B
| $14M | 0.04% |
107,006
-196
| -0.2% | -$27.1K |
|
484
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $13.9M | 0.04% |
135,300
-1,075,820
| -89% | -$109M |
|
485
Designer Brands
DBI
$292M
| $13.8M | 0.04% |
1,020,874
-149,480
| -13% | -$1.98M |
|
486
American Eagle Outfitters
AEO
$2.71B
| $13.8M | 0.04% |
819,980
+501,433
| +157% | +$10.6M |
|
487
Lightspeed Commerce
LSPD
$1.37B
| $13.7M | 0.04% |
450,100
-850,508
| -65% | -$25.3M |
|
488
The RealReal
REAL
$1.35B
| $13.5M | 0.04% |
1,860,053
+1,241,464
| +201% | +$11M |
|
489
Amdocs
DOX
$6.41B
| $13.5M | 0.04% |
163,797
+95,261
| +139% | +$7.46M |
|
|
CUTR
490
DELISTED
Cutera, Inc.
CUTR
| $13.5M | 0.04% |
194,990
+83,482
| +75% | +$3.38M |
|
491
Emergent Biosolutions
EBS
$260M
| $13.5M | 0.04% |
327,617
+84,657
| +35% | +$3.73M |
|
|
BAND
492
Bandwidth Inc
BAND
$1.53B
| $13.4M | 0.04% |
412,870
+409,570
| +12,411% | +$19.6M |
|
493
YPF Sociedad Anonima ADS
YPF
$20.1B
| $13.3M | 0.04% |
2,759,731
+400,917
| +17% | +$1.73M |
|
494
Cigna
CI
$73.3B
| $13.3M | 0.04% |
+55,481
| New | +$13M |
|
495
Essential Properties Realty Trust
EPRT
$6.67B
| $13.3M | 0.04% |
+525,169
| New | +$13.5M |
|
496
Protolabs
PRLB
$1.9B
| $13.3M | 0.04% |
251,052
-235,602
| -48% | -$12.4M |
|
|
RDFN
497
DELISTED
Redfin
RDFN
| $13.2M | 0.04% |
734,308
+680,874
| +1,274% | +$17.5M |
|
498
STAAR Surgical
STAA
$1.16B
| $13.2M | 0.04% |
165,282
+57,836
| +54% | +$4.31M |
|
499
Green Dot
GDOT
$766M
| $13.2M | 0.04% |
480,183
+124,104
| +35% | +$3.77M |
|
|
TCN
500
DELISTED
Tricon Residential Inc.
TCN
| $13.2M | 0.04% |
829,882
-79,822
| -9% | -$1.22M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.